AyuVis Research
PrivateLast Round
Grant
May 15, 2023
Total Funding Raised
$9M
Company Overview
AyuVis Research operates in Healthcare & Life Sciences and is based in Fort Worth, Texas. Its latest recorded funding round was a Grant round in May 2023.
AyuVis Research is a biopharmaceutical company that develops novel small molecule immunotherapies to prevent and treat inflammatory and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AyuVis Research Comparables
Compare AyuVis Research with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Airway Therapeutics | 89% | |
| Advent Therapeutics, Inc. | 86% | |
| orphanix GmbH | 82% |
For institutional investors. Book with your work email.
AyuVis Research Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 15, 2023 | ||||
| Grant | May 12, 2022 | ||||
| Grant | Jan 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AyuVis Research Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
| Cowtown Angels | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 90% MoM.
- Jan 19, 2026
Monthly visitors grew 68% MoM, reaching 1.8K.
For institutional investors. Book with your work email.
AyuVis Research Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AyuVis Research's valuation, stock price, and market status.
Is AyuVis Research a public or private company?
AyuVis Research is a private company.
What is the current stock price of AyuVis Research?
AyuVis Research is a private company, so its shares have no public market price. Caplight tracks AyuVis Research's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AyuVis Research worth (valuation)?
Valuation information for AyuVis Research is not publicly available.
Can I buy AyuVis Research stock?
AyuVis Research shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AyuVis Research's last funding round?
AyuVis Research's most recent funding round was Grant on May 15, 2023.
Who are the main investors in AyuVis Research?
Key investors in AyuVis Research include National Institute of Allergy and Infectious Diseases, National Heart, Lung, and Blood Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Cowtown Angels.
Will AyuVis Research IPO soon?
No public IPO plans have been announced for AyuVis Research.
How can I track AyuVis Research secondary market activity?
Caplight tracks bids, offers, and trades in AyuVis Research's shares on secondary markets.